• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管肺发育不良早产儿的肺动脉高压:一项荟萃分析。

Pulmonary hypertension in preterm neonates with bronchopulmonary dysplasia: a meta-analysis.

作者信息

Mascarenhas Dwayne, Al-Balushi Marwa, Al-Sabahi Aida, Weisz Dany E, Jain Amish, Jasani Bonny

机构信息

The Hospital for Sick Children, Toronto, Ontario, Canada.

Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.

出版信息

Arch Dis Child Fetal Neonatal Ed. 2025 Jun 19;110(4):344-352. doi: 10.1136/archdischild-2024-327547.

DOI:10.1136/archdischild-2024-327547
PMID:39603794
Abstract

CONTEXT

Knowledge gaps exist on the incidence and risk factors for developing pulmonary hypertension (PH) in preterm infants with bronchopulmonary dysplasia (BPD) and its impact on outcomes.

OBJECTIVE

To systematically review and meta-analyse the incidence, risk factors and short- and long-term outcomes of BPD-PH in preterm infants.

DESIGN

PubMed, Embase, Cochrane CENTRAL and CINAHL were searched for studies including infants<37 weeks gestational age (GA) or birth weight<2500 g with BPD-PH versus BPD-no PH from inception until 5 April 2023.

MAIN OUTCOME MEASURES

Incidence, risk factors and short- and long-term outcomes.

RESULTS

44 observational studies evaluating 7677 preterm infants were included. The incidence of PH in mild, moderate and severe BPD was 5%, 18% and 41%, respectively. Small for GA (25 studies; N=5814; OR 1.8; 95% CI 1.3, 2.5), necrotising enterocolitis (22 studies; N=3387; OR 1.6; 95% CI 1.3, 2.2), early PH (four studies; N=820 OR 2.2; 95% CI 1.5, 3.3) and severe BPD (20 studies; N=2587; OR 5.4; 95% CI 3.2, 9.1) were significant risk factors for BPD-PH. Compared with BPD-no PH, the BPD-PH group had significantly higher mortality (22 studies; N=4882; OR 6.4; 95% CI 4.7, 8.6), longer duration of mechanical ventilation, oxygen supplementation, length of hospital stay, need for home oxygen and tracheostomy requirement. The BPD-PH infants also had a significantly higher risk of neurodevelopmental impairment in the motor domain.

CONCLUSIONS

PH increases across the severity of BPD and is associated with higher odds of mortality and adverse short-term and neurodevelopmental outcomes.

PROSPERO REGISTRATION NUMBER

CRD42023413119.

摘要

背景

支气管肺发育不良(BPD)的早产儿发生肺动脉高压(PH)的发病率、危险因素及其对预后的影响方面存在知识空白。

目的

系统评价和荟萃分析早产儿BPD合并PH的发病率、危险因素及短期和长期预后。

设计

检索了PubMed、Embase、Cochrane CENTRAL和CINAHL数据库,纳入自开始至2023年4月5日的研究,研究对象为胎龄<37周或出生体重<2500g的BPD合并PH与不合并PH的婴儿。

主要结局指标

发病率、危险因素及短期和长期预后。

结果

纳入44项观察性研究,共7677例早产儿。轻度、中度和重度BPD中PH的发病率分别为5%、18%和41%。小于胎龄儿(25项研究;N=5814;比值比1.8;95%置信区间1.3,2.5)、坏死性小肠结肠炎(22项研究;N=3387;比值比1.6;95%置信区间1.3,2.2)、早期PH(4项研究;N=820;比值比2.2;95%置信区间1.5,3.3)和重度BPD(20项研究;N=2587;比值比5.4;95%置信区间3.2,9.1)是BPD合并PH的显著危险因素。与不合并PH的BPD组相比,合并PH的BPD组死亡率显著更高(22项研究;N=4882;比值比6.4;95%置信区间4.7,8.6),机械通气时间、吸氧时间、住院时间更长,需要家庭吸氧及气管切开的比例更高。合并PH的BPD婴儿在运动领域神经发育障碍的风险也显著更高。

结论

PH的发生率随BPD严重程度增加而升高,且与更高的死亡几率及不良短期和神经发育结局相关。

PROSPERO注册号:CRD42023413119。

相似文献

1
Pulmonary hypertension in preterm neonates with bronchopulmonary dysplasia: a meta-analysis.支气管肺发育不良早产儿的肺动脉高压:一项荟萃分析。
Arch Dis Child Fetal Neonatal Ed. 2025 Jun 19;110(4):344-352. doi: 10.1136/archdischild-2024-327547.
2
Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.吸入性糖皮质激素与全身性糖皮质激素治疗机械通气的极低出生体重早产儿支气管肺发育不良的比较
Cochrane Database Syst Rev. 2017 Oct 16;10(10):CD002057. doi: 10.1002/14651858.CD002057.pub4.
3
Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.预防性或极早期开始持续气道正压通气(CPAP)治疗早产儿。
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD001243. doi: 10.1002/14651858.CD001243.pub4.
4
Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.吸入性糖皮质激素与全身性糖皮质激素预防机械通气的极低出生体重早产儿支气管肺发育不良的比较
Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD002058. doi: 10.1002/14651858.CD002058.pub3.
5
Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.用于预防早产儿支气管肺发育不良的全身皮质类固醇治疗方案。
Cochrane Database Syst Rev. 2017 Jan 31;1(1):CD010941. doi: 10.1002/14651858.CD010941.pub2.
6
Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.全身皮质类固醇方案预防早产儿支气管肺发育不良。
Cochrane Database Syst Rev. 2023 Mar 13;3(3):CD010941. doi: 10.1002/14651858.CD010941.pub3.
7
Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.超氧化物歧化酶治疗早产儿支气管肺发育不良。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD013232. doi: 10.1002/14651858.CD013232.pub2.
8
Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.晚期(>7天)全身性产后皮质类固醇用于预防早产儿支气管肺发育不良
Cochrane Database Syst Rev. 2017 Oct 24;10(10):CD001145. doi: 10.1002/14651858.CD001145.pub4.
9
Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.早产儿应用晚期(≥7 天)吸入性皮质类固醇以减少支气管肺发育不良。
Cochrane Database Syst Rev. 2022 Dec 15;12(12):CD002311. doi: 10.1002/14651858.CD002311.pub5.
10
Inhaled nitric oxide for respiratory failure in preterm infants.吸入一氧化氮治疗早产儿呼吸衰竭
Cochrane Database Syst Rev. 2007 Jul 18(3):CD000509. doi: 10.1002/14651858.CD000509.pub3.

引用本文的文献

1
Risk Factors for Severe Respiratory Morbidity at 2 Years of Life in Children Born Extremely Preterm With Bronchopulmonary Dysplasia.极早早产并患有支气管肺发育不良的儿童2岁时严重呼吸道疾病的危险因素
Pediatr Pulmonol. 2025 Aug;60(8):e71258. doi: 10.1002/ppul.71258.
2
Risk Factors Associated With the Development of Late Pulmonary Artery Hypertension in Extremely Premature Infants.极早早产儿迟发性肺动脉高压发生的相关危险因素
Pediatr Pulmonol. 2025 Feb;60(2):e27501. doi: 10.1002/ppul.27501.